SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934
(Amendment No.__)

Filed by the Registrant

Filed by a Party other than the Registrant

Check the appropriate box:
    Preliminary Proxy Statement
    Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
    Definitive Proxy Statement
    Definitive Additional Materials
    Soliciting Material Pursuant to §240.14a-12

ARROWHEAD PHARMACEUTICALS, INC.

image_0.jpg
(Name of Registrant as Specified In Its Charter)
image_1.jpg
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
    No fee required.
    Fee paid previously with preliminary materials
    Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.

image_2.jpg

image_17.jpg
image_17.jpg


a0001.jpg


a0002.jpg

Arrowhead Pharmaceuticals (NASDAQ:ARWR)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024 Arrowhead Pharmaceuticals 차트를 더 보려면 여기를 클릭.
Arrowhead Pharmaceuticals (NASDAQ:ARWR)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024 Arrowhead Pharmaceuticals 차트를 더 보려면 여기를 클릭.